May 8, 2018 / 11:25 AM / 6 months ago

BRIEF-Proteon Therapeutics And Lonza Extend Manufacturing Agreement For Commercial Supply

May 8 (Reuters) - Proteon Therapeutics Inc:

* PROTEON THERAPEUTICS AND LONZA EXTEND MANUFACTURING AGREEMENT FOR COMMERCIAL SUPPLY

* PROTEON THERAPEUTICS INC - PARTNERS EXTEND EXISTING CONTRACT FOR MANUFACTURE OF VONAPANITASE TO 2029 AS ONGOING PHASE 3 TRIAL NEARS COMPLETION

* PROTEON THERAPEUTICS - CONTRACT EXTENSION WITH LONZA PHARMA & BIOTECH FOR COMMERCIAL SUPPLY OF INVESTIGATIONAL VONAPANITASE’S API Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below